Literature DB >> 10091145

Multicentre study on prevalence of fractures in transfusion-dependent thalassaemic patients.

L Ruggiero1, V De Sanctis.   

Abstract

The objective of this study was to determine the prevalence of fractures in transfusion-dependent thalassaemic patients in Italy. Examination of the patients' records revealed that 193 of the 977 observed patients had sustained fractures, with prevalence of 19.7%. Many patients showed multiple and recurrent fractures. Children and adolescents sustained fractures more frequently than adults. The majority of observed patients sustained fractures because of moderate or mild trauma. Our results seem to indicate that Hb pretransfusional levels over 9 or 10 gr% and serum ferritin levels under 1,000 ng/ml cannot always prevent the risk of fracture.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10091145

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  11 in total

Review 1.  Endocrine complications of thalassemia.

Authors:  D Tiosano; Z Hochberg
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

2.  Prevalence of fractures among the Thalassemia syndromes in North America.

Authors:  M G Vogiatzi; E A Macklin; E B Fung; E Vichinsky; N Olivieri; J Kwiatkowski; A Cohen; E Neufeld; P J Giardina
Journal:  Bone       Date:  2005-11-17       Impact factor: 4.398

3.  Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices.

Authors:  Rashid Merchant; Amish Udani; Vipla Puri; Valentina D'cruz; Deepak Patkar; Aarti Karkera
Journal:  Indian J Pediatr       Date:  2010-08-25       Impact factor: 1.967

Review 4.  Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major.

Authors:  Fabio Pellegrino; Maria Chiara Zatelli; Marta Bondanelli; Aldo Carnevale; Corrado Cittanti; Monica Fortini; Maria Rita Gamberini; Melchiore Giganti; Maria Rosaria Ambrosio
Journal:  Endocrine       Date:  2019-07-12       Impact factor: 3.633

5.  Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.

Authors:  Nunziata Morabito; Antonino Catalano; Agostino Gaudio; Elisabetta Morini; Lucia Maria Bruno; Giorgio Basile; Eleni Tsiantouli; Federica Bellone; Rita Maria Agostino; Basilia Piraino; Maria Angela La Rosa; Carmelo Salpietro; Antonino Lasco
Journal:  J Bone Miner Metab       Date:  2015-07-24       Impact factor: 2.626

Review 6.  Fracture prevalence in thalassemia: a systematic review and meta-analysis.

Authors:  Nipith Charoenngam; Thanitsara Rittiphairoj; Ben Ponvilawan
Journal:  Arch Osteoporos       Date:  2021-11-13       Impact factor: 2.617

Review 7.  Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507

Review 8.  Bisphosphonates in the treatment of thalassemia-associated osteoporosis.

Authors:  A Gaudio; N Morabito; A Xourafa; I Macrì; A Meo; S Morgante; A Trifiletti; A Lasco; N Frisina
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

Review 9.  Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss.

Authors:  Viktória Jeney
Journal:  Front Pharmacol       Date:  2017-02-21       Impact factor: 5.810

Review 10.  Influence of Iron on Bone Homeostasis.

Authors:  Enikő Balogh; György Paragh; Viktória Jeney
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.